Benzinga's Top #PreMarket Losers By: Benzinga via Benzinga September 26, 2014 at 08:08 AM EDT AcelRx Pharmaceuticals (NASDAQ: ACRX) shares slipped 10.71% to $6.00 in pre-market trading after the company offered a regulatory update ... Read More >> Related Stocks: Acelrx Pharmaceutica Philip Morris International The Finish Line, Inc. - Class A Common Stock